Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2021

Apr 6, 2021

30870_dirs_2021-04-05_5c125e3c-06c0-43af-9f8b-6e00eb45fd41.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2021-04-01

Reporting Person: HENDERSON JOHN T (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-04-01 Common Stock M 1133 $8.64 Acquired 8543 Direct
2021-04-01 Common Stock S 1133 $24.0 Disposed 7410 Direct
2021-04-01 Common Stock M 1100 $8.64 Acquired 8510 Direct
2021-04-01 Common Stock S 1100 $23.31 Disposed 7410 Direct
2021-04-01 Common Stock M 1100 $8.64 Acquired 8510 Direct
2021-04-01 Common Stock S 1100 $23.31 Disposed 7410 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-04-01 Non-Qualified Stock Option (right to buy) $8.64 M 1133 Disposed 2021-05-18 Common Stock (1133) Direct
2021-04-01 Non-Qualified Stock Option (right to buy) $8.64 M 1100 Disposed 2021-05-18 Common Stock (1100) Direct
2021-04-01 Non-Qualified Stock Option (right to buy) $8.64 M 1100 Disposed 2021-05-18 Common Stock (1100) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 83 Indirect

Footnotes

F1: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 2, 2021

F2: Amount includes 511 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program.